NYSE - Delayed Quote • USD
Warby Parker Inc. (WRBY)
At close: May 17 at 4:00 PM EDT
After hours: May 17 at 6:03 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 5 | 6 |
| Avg. Estimate | 0.05 | 0.06 | 0.21 | 0.29 |
| Low Estimate | 0.04 | 0.04 | 0.17 | 0.24 |
| High Estimate | 0.06 | 0.09 | 0.25 | 0.34 |
| Year Ago EPS | 0.04 | 0.01 | 0.1 | 0.21 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 13 | 13 |
| Avg. Estimate | 186.96M | 190.77M | 760.15M | 858.47M |
| Low Estimate | 185.8M | 188.8M | 756.94M | 841.9M |
| High Estimate | 190.05M | 196.39M | 767.52M | 872.8M |
| Year Ago Sales | 166.09M | 164.59M | 669.76M | 760.15M |
| Sales Growth (year/est) | 12.60% | 15.90% | 13.50% | 12.90% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.02 | 0.01 | 0.01 | 0.07 |
| EPS Actual | 0.04 | 0.01 | -0.01 | 0.11 |
| Difference | 0.02 | 0 | -0.02 | 0.04 |
| Surprise % | 100.00% | 0.00% | -200.00% | 57.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.05 | 0.06 | 0.21 | 0.29 |
| 7 Days Ago | 0.04 | 0.05 | 0.18 | 0.27 |
| 30 Days Ago | 0.05 | 0.05 | 0.18 | 0.28 |
| 60 Days Ago | 0.04 | 0.05 | 0.18 | 0.27 |
| 90 Days Ago | 0.04 | 0.01 | 0.19 | 0.28 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 5 | 5 | 7 | 6 |
| Up Last 30 Days | 5 | 6 | 8 | 8 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | 1 | -- |
Growth Estimates
| CURRENCY IN USD | WRBY | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 25.00% | -- | -- | 8.00% |
| Next Qtr. | 500.00% | -- | -- | 12.40% |
| Current Year | 110.00% | -- | -- | 5.60% |
| Next Year | 38.10% | -- | -- | 13.00% |
| Next 5 Years (per annum) | -- | -- | -- | 11.14% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | UBS: Neutral to Neutral | 5/10/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 5/10/2024 |
| Maintains | Telsey Advisory Group: Outperform to Outperform | 5/9/2024 |
| Reiterates | Telsey Advisory Group: Outperform to Outperform | 2/28/2024 |
| Reiterates | Telsey Advisory Group: Outperform to Outperform | 2/21/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 1/24/2024 |
Related Tickers
EMBC Embecta Corp.
14.45
+1.76%
XRAY DENTSPLY SIRONA Inc.
28.28
-0.35%
COO The Cooper Companies, Inc.
97.31
-0.60%
BAX Baxter International Inc.
35.25
+0.23%
RMD ResMed Inc.
218.57
-0.64%
WST West Pharmaceutical Services, Inc.
355.64
+0.43%
ALC Alcon Inc.
88.83
-0.26%
ATRI Atrion Corporation
465.25
+2.06%
BLFS BioLife Solutions, Inc.
21.96
-0.05%
TFX Teleflex Incorporated
217.64
-0.43%